ERIC Workshop on MRD Analysis in Chronic Lymphocytic Leukemia


 

Venetoclax and Ibrutinib in Relapsed/Refractory CLL & Overview of Trials Using Combinations in Frontline Setting

195 views
June 26, 2019
0 Comments
Login to view comments. Click here to Login